Hyperliquid Strategies (NASDAQ:PURR) Hits New 12-Month High – Time to Buy?

Hyperliquid Strategies Inc (NASDAQ:PURR)’s share price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $12.10 and last traded at $11.87, with a volume of 29708674 shares traded. The stock had previously closed at $10.64.

Key Headlines Impacting Hyperliquid Strategies

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: HYPE treasury expanded: The company said it more than doubled its HYPE holdings, with reports highlighting a treasury of approximately 29.3 million tokens. The increase strengthens PURR’s position as a digital-asset treasury vehicle and gives shareholders greater exposure to HYPE’s performance. HYPE Price Jumps 5% as Hyperliquid Strategies Grows Treasury to 29.3M Tokens
• Positive Sentiment: Strong fiscal 2026 update: Management said it built the platform, expanded its HYPE treasury, jointly launched a validator that quickly became one of the largest on the network, and completed its exit from legacy biotech operations. The strategic shift provides a clearer crypto-focused investment story. Hyperliquid Strategies Inc Reports Financial Results for the Fiscal Year Ended June 30, 2026
• Positive Sentiment: Crypto momentum and investor enthusiasm: HYPE reportedly reached an all-time high, while coverage described PURR’s balance sheet as a “fortress.” Rising HYPE prices can increase the value of PURR’s treasury and reinforce the company’s asset-backed investment thesis. PURR Stock Price Rips To New Record As HYPE Hits All-Time High
• Neutral Sentiment: Chardan Capital reaffirmed its “buy” rating, but its $9.75 price target is below the stock’s recent trading level, suggesting the analyst sees valuation and execution risks after the rally. Benzinga
• Negative Sentiment: PURR remains highly dependent on HYPE and broader cryptocurrency sentiment. A decline in HYPE’s price could reduce the value of the company’s treasury and pressure the stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on PURR. Weiss Ratings raised shares of Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 3rd. Cantor Fitzgerald set a $22.60 target price on shares of Hyperliquid Strategies and gave the stock an “overweight” rating in a research note on Thursday. Finally, Chardan Capital restated a “buy” rating and issued a $9.75 target price on shares of Hyperliquid Strategies in a report on Thursday. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $14.12.

Hyperliquid Strategies Price Performance

The stock has a fifty day simple moving average of $7.81 and a two-hundred day simple moving average of $6.85. The firm has a market capitalization of $1.85 billion, a P/E ratio of -1.74 and a beta of 1.71.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new position in Hyperliquid Strategies during the second quarter worth $79,842,000. Paradigm Operations LP bought a new stake in Hyperliquid Strategies in the fourth quarter valued at $20,327,000. Galaxy Group Investments LLC acquired a new position in shares of Hyperliquid Strategies during the fourth quarter valued at about $15,167,000. Pantera Capital Partners LP acquired a new position in shares of Hyperliquid Strategies during the fourth quarter valued at about $14,545,000. Finally, Feynman Point Asset Management LLC bought a new position in shares of Hyperliquid Strategies during the 4th quarter worth about $14,431,000. Institutional investors and hedge funds own 9.45% of the company’s stock.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.